JOINN(06127)

14.500-1.500-9.37%

Market data delayed 15 minutes

    • Smartkarma
      ·
      2024-05-02

      Joinn Laboratories (6127 HK) - Waiting longer for recovery to materialize

      ⬆ $Joinn Laboratories China Lt(06127)$ - Joinn reported 1Q24 revenue of RMB325mn, down 12.1% YoY, and booked attributable net loss of RMB272mn, a significant downturn from an attributable net profit of RMB188mn in 1Q23. Continue reading on Smartkarma:- https://www.smartkarma.com/insights/joinn-laboratories-6127-hk-waiting-longer-for-recovery-to-materialize?utm_source=tiger_community By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community On Joinn Laboratories China Lt (06127):- https://www.smartkarma.com/entities/joinn-laboratories-china-co-lt-48e8081a-4bcf-4432-bc1d-5da143f0abfb?utm_source=tiger_community
      Joinn Laboratories (6127 HK) - Waiting longer for recovery to materialize
      Comment
      Report
      Smartkarma
      ·
      2023-11-02

      Joinn Laboratories (6127 HK) – Wait longer for recovery

      ⬇ $Joinn Laboratories China Lt(06127)$ - Joinn reported 3Q23 revenue of RMB575mn, up 15.1% YoY, and attributable net income of RMB237mn, down 9.2% YoY. 3Q23 revenue accounted for 20.7% of... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/joinn-laboratories-6127-hk-wait-longer-for-recovery?utm_source=tiger_community By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community On Joinn Laboratories China Lt (06127):- https://www.smartkarma.com/entities/joinn-laboratories-china-co-lt-48e8081a-4bcf-4432-bc1d-5da143f0abfb?utm_source=tiger_community
      Joinn Laboratories (6127 HK) – Wait longer for recovery
      Comment
      Report
      Smartkarma
      ·
      2023-07-17

      Joinn Laboratories (6127 HK) – Core Business Maintains a Healthy Growth Momentum

      ⬆ $Joinn Laboratories (H)(06127)$ - Joinn released estimated preliminary results for 1H23E, expecting revenue of RMB973-1,051mn, up 25.3-35.3% YoY, and attributable net income of RMB73- 110mn Continue reading on Smartkarma:- https://www.smartkarma.com/insights/joinn-laboratories-6127-hk-core-business-maintains-a-healthy-growth-momentum?utm_source=tiger_community By CMB International, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cmb-international?utm_source=tiger_community On Joinn Laboratories (H) (06127):- https://www.smartkarma.com/entities/joinn-laboratories-china-c-h?utm_source=tiger_community
      Joinn Laboratories (6127 HK) – Core Business Maintains a Healthy Growth Momentum
      Comment
      Report
      sleepycoffee
      ·
      2021-06-20
      Joinn

      【老虎7週年】集卡瓜分百萬獎金

      @小虎活动
      老虎7週年給大家發福利了,集齊TIGER五個字母即有機會瓜分百萬獎金,你準備好了嗎? 戳我即可參與活動 如何參與? 用戶可通過完成活動頁面展示的當日任務列表來獲得字母卡,每完成一個任務即可隨機獲得一個字母,用戶集齊“TIGER”五個字母即可參與瓜分百萬股票代金券,每個用戶單日最多可獲得20張字母卡(不包括好友贈予和魔法卡)。 用戶在活動期間邀請累計7名好友完成註冊並開戶(註冊時間和開戶時間均在活動期間),即可獲得一張魔法卡(每人僅可獲得一張魔法卡)。魔法卡可用於兌換TIGER中的任意一個字母。如果用戶的某一字母卡數量爲0,則字母卡爲灰色,用戶可通過點擊灰色的字母卡向好友索要卡片;如果用戶的字母卡數量大於0,則字母卡爲彩色,用戶可通過點擊彩色的字母卡向好友贈送卡片。當用戶集齊TIGER之後將無法再索要卡片或者贈送卡片。  如何獲得獎勵? 用戶可在2021年7月1日至2021年7月2日期間進行開獎,所有集齊TIGER的客戶可點擊活動頁面的“開獎”按鈕,即可查看自己瓜分到的股票代金券獎勵。在開獎時間段內未點擊開獎的用戶將無法獲得獎勵。 獎勵發放: 股票代金券將在開獎後的1個工作日內發放至用戶的獎勵中心,用戶需要在獎勵發放後的20天內前往【Tiger Trade APP > 我的 > 活動獎勵】領取,過期未領取的獎勵將自動失效。 重要提示: 本次7週年活動涉及不同國家和地區,由於各地區的監管要求不同,不同地區的活動獎勵會有所區別。欲知詳情,請點擊下方活動鏈接,登陸您的賬號,並點擊“活動規則“查看詳情。
      【老虎7週年】集卡瓜分百萬獎金
      Joinn
      1
      Report
      jaky979977
      ·
      2021-02-26
      Comment
      Report
  • Company Profile

    Company Name
    JOINN
    Market
    SEHK
    Establishment Date
    1995
    Employees
    2510
    Office Location
    A5 Rongjing East Street,Beijing Eco-Techno Development Area,Beijing,China
    Website
    - -
    Zip Code
    100176
    Fax
    86 10 6786 9966
    Introduction
    Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.

    Industry

    Life Sciences Tools & Services

    IPO Information

    Listing Date
    2021-02-25
    Issue Price
    151
    • 1D
    • 5D
    • Day
    • Week
    • Month
    High
    16.360
    Open
    16.000
    Volume%
    2.02
    Low
    14.020
    Close
    16.000
    T/O Rate
    3.87%
    errorbox banner

    抱歉,当前请求异常(-1)

    Company: TTMF Limited. Tech supported by Xiangshang Yixin.

    Email:uservice@ttm.financial